[HTML][HTML] Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease
Background: We hypothesize that the poor survival outcomes of end-stage kidney disease
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …
Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease
W Lin, F Mousavi, BC Blum… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Background: We hypothesize that the poor survival outcomes of end-stage kidney disease
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …
[HTML][HTML] Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease
W Lin, F Mousavi, BC Blum, CF Heckendorf… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background: We hypothesize that the poor survival outcomes of end-stage kidney disease
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …
Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease
W Lin, F Mousavi, BC Blum… - Frontiers in …, 2023 - ohsu.elsevierpure.com
Background: We hypothesize that the poor survival outcomes of end-stage kidney disease
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …
Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease
W Lin, F Mousavi, B Blum, C Heckendorf… - Frontiers in …, 2023 - europepmc.org
Background: We hypothesize that the poor survival outcomes of end-stage kidney disease
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …
[引用][C] Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease
W Lin, F Mousavi, BC Blum, CF Heckendorf… - Frontiers in …, 2023 - jglobal.jst.go.jp
Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in
end-stage kidney disease | Article Information | J-GLOBAL Art J-GLOBAL ID:202402256505531675 …
end-stage kidney disease | Article Information | J-GLOBAL Art J-GLOBAL ID:202402256505531675 …
Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease.
W Lin, F Mousavi, BC Blum, CF Heckendorf… - Frontiers in …, 2023 - europepmc.org
Background: We hypothesize that the poor survival outcomes of end-stage kidney disease
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …
(ESKD) patients undergoing hemodialysis are associated with a low filtering efficiency and …